National Cancer Institute creates research network for COVID-19 immunity: 4 things to know

The National Cancer Institute is launching a research network to increase the nation's antibody testing capacity and better understand immune response to COVID-19. 

Four things to know:

1. The Serological Sciences Network, known as SeroNet, represents the largest coordinated effort to study COVID-19 immunity in the U.S.

2. The initiative will provide grants for researchers to study immune response and then use those findings to develop COVID-19 blood tests and treatments. 

3. Twenty-five biomedical research institutions will participate in the network nationwide. 

4. SeroNet is supported by $306 million in emergency funds allocated by Congress.

Learn more about the initiative here.

More articles on public health:
COVID-19 hospitalizations by state: Oct. 8
21 states where COVID-19 is spreading fastest, slowest: Oct. 8
34 COVID-19 cases tied to White House; Wisconsin to open field hospital amid surge — 5 COVID-19 updates

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers